Feng Cheng

2.7k total citations · 1 hit paper
91 papers, 1.6k citations indexed

About

Feng Cheng is a scholar working on Surgery, Molecular Biology and Epidemiology. According to data from OpenAlex, Feng Cheng has authored 91 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Surgery, 26 papers in Molecular Biology and 18 papers in Epidemiology. Recurrent topics in Feng Cheng's work include Organ Transplantation Techniques and Outcomes (18 papers), Liver Disease and Transplantation (11 papers) and Trace Elements in Health (7 papers). Feng Cheng is often cited by papers focused on Organ Transplantation Techniques and Outcomes (18 papers), Liver Disease and Transplantation (11 papers) and Trace Elements in Health (7 papers). Feng Cheng collaborates with scholars based in China, United States and United Kingdom. Feng Cheng's co-authors include Xuehao Wang, Jianhua Rao, Ling Lü, Shikun Yang, Jiannan Qiu, Haoming Zhou, Ming Ni, Wenjie Yang, Yuanchang Hu and Liyong Pu and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Feng Cheng

80 papers receiving 1.6k citations

Hit Papers

FSTL1 promotes liver fibrosis by reprogramming macrophage... 2022 2026 2023 2024 2022 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2
    2022 152 citations Jianhua Rao, Hao Wang et al. Gut profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feng Cheng China 25 584 303 298 280 273 91 1.6k
Masashi Kato Japan 26 464 0.8× 433 1.4× 424 1.4× 195 0.7× 143 0.5× 158 2.6k
Anna Severino Italy 23 679 1.2× 265 0.9× 270 0.9× 97 0.3× 275 1.0× 58 1.5k
Rong Cong China 21 1.3k 2.3× 243 0.8× 411 1.4× 726 2.6× 176 0.6× 92 2.4k
Huaiyong Chen China 24 767 1.3× 400 1.3× 332 1.1× 162 0.6× 328 1.2× 69 2.3k
Min Shen China 28 1.4k 2.4× 212 0.7× 443 1.5× 557 2.0× 353 1.3× 155 2.6k
Juan Zhang China 26 936 1.6× 634 2.1× 310 1.0× 574 2.0× 143 0.5× 164 2.2k
Jiaan‐Der Wang Taiwan 23 307 0.5× 262 0.9× 95 0.3× 99 0.4× 222 0.8× 100 1.5k

Countries citing papers authored by Feng Cheng

Since Specialization
Citations

This map shows the geographic impact of Feng Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Cheng more than expected).

Fields of papers citing papers by Feng Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Cheng. The network helps show where Feng Cheng may publish in the future.

Co-authorship network of co-authors of Feng Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Feng Cheng. A scholar is included among the top collaborators of Feng Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng Cheng. Feng Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peng, Yujie, et al.. (2025). Stable, high-performance vertical heterojunction ultraviolet photodetectors with Ga2O3-protected Ag nanowires window electrode. SHILAP Revista de lepidopterología. 4(3). 313–320.
2.
Chao, Jiashuo, Yuan Liang, Hao Wang, et al.. (2025). FAD synthase confers ferroptosis resistance and restrains CD8+ T cell recruitment in hepatocellular carcinoma. Nature Communications. 16(1). 9547–9547.
3.
Cheng, Feng, et al.. (2025). Bioequivalence study of fluticasone propionate nebuliser suspensions in healthy Chinese subjects. Frontiers in Pharmacology. 15. 1452596–1452596.
4.
5.
Rao, Jianhua, Zeng Wang, Fei Yu, et al.. (2024). XBP1 Facilitating NF-κB-p65 Nuclear Translocation Promotes Macrophage-Originated Sterile Inflammation Via Regulating MT2 Transcription in the Ischemia/Reperfusion Liver. Cellular and Molecular Gastroenterology and Hepatology. 18(6). 101402–101402. 1 indexed citations
6.
Rao, Jianhua, Hao Wang, Ming Ni, et al.. (2022). FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2. Gut. 71(12). 2539–2550. 152 indexed citations breakdown →
7.
Lamson, Angela L., et al.. (2022). Medical Family Therapy in Rural Community Health: A Longitudinal “Peek” into Integrated Care Successes. Contemporary Family Therapy. 44(1). 29–43.
8.
Yang, Chao, Yuanchang Hu, Shikun Yang, et al.. (2022). Hyperglycemia-triggered ATF6-CHOP pathway aggravates acute inflammatory liver injury by β-catenin signaling. Cell Death Discovery. 8(1). 115–115. 13 indexed citations
9.
Yang, Wenjie, Yong Ni, Shikun Yang, et al.. (2021). The oncogene Mct-1 promotes progression of hepatocellular carcinoma via enhancement of Yap-mediated cell proliferation. Cell Death Discovery. 7(1). 57–57. 1 indexed citations
10.
Zhou, Haoming, Shun Zhou, Yong Shi, et al.. (2020). TGR5/Cathepsin E signaling regulates macrophage innate immune activation in liver ischemia and reperfusion injury. American Journal of Transplantation. 21(4). 1453–1464. 32 indexed citations
11.
Cheng, Feng, et al.. (2020). A serum lipidomic strategy revealed potential lipid biomarkers for early-stage cervical cancer. Life Sciences. 260. 118489–118489. 22 indexed citations
12.
13.
Yang, Wenjie, Shikun Yang, Feng Zhang, et al.. (2020). Influence of the Hippo-YAP signalling pathway on tumor associated macrophages (TAMs) and its implications on cancer immunosuppressive microenvironment. Annals of Translational Medicine. 8(6). 399–399. 58 indexed citations
14.
Lu, Xiaocheng, et al.. (2014). Neurogenin 2 enhances the neuronal differentiation of skin-derived precursors. International Journal of Neuroscience. 125(5). 367–374. 7 indexed citations
15.
Cheng, Feng, et al.. (2014). Neurogenin 2 Converts Mesenchymal Stem Cells into a Neural Precursor Fate and Improves Functional Recovery after Experimental Stroke. Cellular Physiology and Biochemistry. 33(3). 847–858. 17 indexed citations
16.
DeSilva, Mary Bachman, Allen L. Gifford, Keyi Xu, et al.. (2013). Feasibility and Acceptability of a Real-Time Adherence Device among HIV-Positive IDU Patients in China. AIDS Research and Treatment. 2013. 1–6. 46 indexed citations
17.
Sun, Xiaodong, et al.. (2010). Neurosyphilis presenting as diplopia: a literature review.. The Chinese Journal of Dermatovenereology. 24(6). 543–545. 1 indexed citations
18.
Cheng, Feng, et al.. (2009). De novo phyllodes tumor in an adolescent female after liver transplantation. Pediatric Transplantation. 15(1). E12–4. 3 indexed citations
19.
Wang, Xuehao, Lünan Yan, Feng Zhang, et al.. (2006). Early experiences on living donor liver transplantation in China: multicenter report. Chinese Medical Journal. 119(12). 1003–1009. 14 indexed citations
20.
Cheng, Feng, et al.. (1969). Significance of early and late positive responses to insulin hypoglycaemia in patients with intact vagi. Gut. 10(10). 820–824. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masashi Kato Breakdown of academic impact, for papers by Anna Severino Breakdown of academic impact, for papers by Rong Cong Breakdown of academic impact, for papers by Huaiyong Chen Breakdown of academic impact, for papers by Min Shen Breakdown of academic impact, for papers by Juan Zhang Breakdown of academic impact, for papers by Jiaan‐Der Wang
Rankless by CCL
2026